 Pliant Therapeutics Inc NASDAQ: PLRX says that with just two FDA-approved Idiopathic Pulmonary Fibrosis drugs, it believes that is a high unmet need. Roche Holdings AGs OTC: RHHBY Esbriet and Boehringer Ingelheims Ofev have around 4 billion combined U.S. sales. 